The post DOGE, PEPE, and SHIB Rally Amid Renewed Meme Coins Interest appeared on BitcoinEthereumNews.com. Key Insights: The recent performance of meme coins indicatesThe post DOGE, PEPE, and SHIB Rally Amid Renewed Meme Coins Interest appeared on BitcoinEthereumNews.com. Key Insights: The recent performance of meme coins indicates

DOGE, PEPE, and SHIB Rally Amid Renewed Meme Coins Interest

For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com

Key Insights:

  • The recent performance of meme coins indicates that the segment is not dead yet.
  • Dogecoin, Pepe, and Shiba Inu pull off impressive double-digit gains.
  • Whale orders reveal interesting details about the current rally and whether it will last.

2025 was overall bearish for meme coins, particularly in terms of price action. The top three cryptocurrencies in the segment by market cap, namely Dogecoin (DOGE), Shiba Inu (SHIB), and Pepe (PEPE), all closed the year in the red, with sizable discounts.

To put into perspective how far meme coins fell from grace in 2025, DOGE tanked by 62% from its opening to closing price for the year. SHIB retreated by 67%, while PEPE knocked off 67% from its value in the last 12 months.

Meme Coin: PEPE, SHIB, & DOGE Price Action | Source: TradingView

The meme coin segment was so bearish in 2025 that it ranked among the top crypto narratives that failed in 2025. The performance of the meme coins segment was largely due to the shift towards institutional liquidity and real-world assets (RWAs) in 2025.

DOGE, PEPE, & SHIB Kick Off 2026 with Double-Digit Gains

The narrative shift took away investor attention and set the pace for heavy liquidity outflows in 2025. As a result, investors have been curious as to whether meme coins could still make a comeback in 2026, considering their substantial discounts.

Interestingly, the meme coins segment appears to have kicked off 2026 with robust bullish momentum. According to latest market data, DOGE was up 15% in the last 7 days, with most of those gains occurring in the last 2 days.

SHIB pulled off a modest 8% uptick during the same period. PEPE was more dramatic, with gains of 47% in the last 7 days at the time of observation. PEPE and DOGE’s impressive double digits confirmed robust interest in the segment.

This renewed interest suggests that smart money was well-positioned to leverage upside potential after the heavily discounted prices observed in 2025. This bullish outcome among the top meme coins confirmed the return of speculative appetite.

Although a bullish relief for the meme coins confirmed interest in discounted opportunities without a narrative bias, it also raised questions. For example, will the meme coins segment experience a deeper recovery, or is this rally a trap?

Whale Activity Reveals More Details on Meme Coins Rally

Whale activity at any given point in the market reveals critical data about their positioning. For instance, increased market confidence and deeper recovery expectations encourage deeper exposure.

On the other hand, whales tend to dip their toes in the market with more conservative liquidity levels when uncertainty is high. This then yields a brief bullish relief.

Dogecoin’s large order book data revealed that in the last 2 days, whales acquired about $3.4 million worth of BTC on Binance spot and around $787,000 on Coinbase.  Whale net inflows on OKX were higher at $1.5 million.

In the derivatives segment, net longs were knocking on $96 million on Binance perps and just over $25.5 million on OKX perps. SHIB demand on both the spot and derivatives segments was much more subdued, with none of the exchanges crossing above $1 million.

PEPE whales had $6 million in net inflows on OKX and $5 million on Binance. OKX perps revealed $10 million in net shorts.

While the three meme coins demonstrated a significant demand surge, it was still notably low. This may indicate limited upside, but the bulls might prevail if demand continues to build.

Source: https://www.thecoinrepublic.com/2026/01/04/doge-pepe-and-shib-rally-amid-renewed-meme-coins-interest/

Market Opportunity
DOGE Logo
DOGE Price(DOGE)
$0.09036
$0.09036$0.09036
+0.11%
USD
DOGE (DOGE) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Key Takeaways Vitalik Buterin wants Ethereum apps built to survive without developers, corporate servers, or trusted third parties Two major […] The post Vitalik
Share
Coindoo2026/03/07 15:49
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

The post Short-term profit-taking pushes Bitcoin back below key $70K level – What next? appeared on BitcoinEthereumNews.com. Bitcoin [BTC] rallied as high as $74
Share
BitcoinEthereumNews2026/03/07 16:09